First, we evaluated the expression of all six selected wnt/β-catenin pathway target genes, AXIN2, ATOH1, BCL9L, ISL1, SOX1 and NKX2.2 in NTD samples. This evidence concerns the gene NKX2-2 and neural tube defect.